Skip to main content
Top
Published in: Pituitary 1/2017

Open Access 01-02-2017

Epidemiology of acromegaly: review of population studies

Authors: Aikaterini Lavrentaki, Alessandro Paluzzi, John A. H. Wass, Niki Karavitaki

Published in: Pituitary | Issue 1/2017

Login to get access

Abstract

Acromegaly is a rare condition necessitating large population studies for the generation of reliable epidemiological data. In this review, we systematically analysed the epidemiological profile of this condition based on recently published population studies from various geographical areas. The total prevalence ranges between 2.8 and 13.7 cases per 100,000 people and the annual incidence rates range between 0.2 and 1.1 cases/100,000 people. The median age at diagnosis is in the fifth decade of life with a median diagnostic delay of 4.5–5 years. Acral enlargement and coarse facial features are the most commonly described clinical manifestations. At the time of detection, most of the tumors are macroadenomas possibly relating to diagnostic delays and posing challenges in the surgical management. Increased awareness of acromegaly amongst the medical community is of major importance aiming to reduce the adverse sequelae of late diagnosis and treatment, improve patient outcomes and, hopefully, reduce the burden on the health care system.
Literature
2.
go back to reference Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951CrossRefPubMed Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951CrossRefPubMed
3.
go back to reference Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377–382CrossRef Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377–382CrossRef
4.
go back to reference Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross- sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91(12):4769–4775CrossRefPubMed Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross- sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91(12):4769–4775CrossRefPubMed
5.
go back to reference Tjörnstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, Rosén T, Filipsson Nyström H (2014) The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011. Eur J Endocrinol 171(4):519–526CrossRefPubMed Tjörnstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, Rosén T, Filipsson Nyström H (2014) The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011. Eur J Endocrinol 171(4):519–526CrossRefPubMed
6.
go back to reference Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, Thorsson AV, Carroll PV, Korbonits M, Benediktsson R (2015) The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study. Eur J Endocrinol 173(5):655–664CrossRefPubMed Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, Thorsson AV, Carroll PV, Korbonits M, Benediktsson R (2015) The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study. Eur J Endocrinol 173(5):655–664CrossRefPubMed
7.
go back to reference Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA (2015) The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013. Pituitary 18:803–807CrossRefPubMed Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA (2015) The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013. Pituitary 18:803–807CrossRefPubMed
8.
go back to reference Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95(9):4268–4275CrossRefPubMed Raappana A, Koivukangas J, Ebeling T, Pirilä T (2010) Incidence of pituitary adenomas in Northern Finland in 1992–2007. J Clin Endocrinol Metab 95(9):4268–4275CrossRefPubMed
9.
go back to reference Dal J, Feldt-Rasmussen U, Andersen M, Kristensen LØ, Laurberg P, Pedersen L, Dekkers OM, Sørensen HT, Jorgensen JO (2016) Acromegaly incidence, prevalence, complications, and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):1810190CrossRef Dal J, Feldt-Rasmussen U, Andersen M, Kristensen LØ, Laurberg P, Pedersen L, Dekkers OM, Sørensen HT, Jorgensen JO (2016) Acromegaly incidence, prevalence, complications, and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):1810190CrossRef
10.
go back to reference Bex M, Abs R, T’Sjoen G, Mockel J, Velkeniers B, Muermans K, Maiter D (2007) AcroBel–the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects. Eur J Endocrinol 157(4):399–409CrossRefPubMed Bex M, Abs R, T’Sjoen G, Mockel J, Velkeniers B, Muermans K, Maiter D (2007) AcroBel–the Belgian registry on acromegaly: a survey of the ‘real-life’ outcome in 418 acromegalic subjects. Eur J Endocrinol 157(4):399–409CrossRefPubMed
11.
go back to reference Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151(4):439–446CrossRefPubMed Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151(4):439–446CrossRefPubMed
12.
go back to reference Gruppetta M, Mercieca C, Vassallo J (2013) Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary 16(4):545–553CrossRefPubMed Gruppetta M, Mercieca C, Vassallo J (2013) Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary 16(4):545–553CrossRefPubMed
13.
14.
go back to reference Kwon O, Song YD, Kim SY, Lee EJ, Rare Disease Study Group, Science and Research Committee, Korean Endocrine Society (2013) Nationwide survey of acromegaly in South Korea. Clin Endocrinol (Oxf) 78(4):577–585CrossRef Kwon O, Song YD, Kim SY, Lee EJ, Rare Disease Study Group, Science and Research Committee, Korean Endocrine Society (2013) Nationwide survey of acromegaly in South Korea. Clin Endocrinol (Oxf) 78(4):577–585CrossRef
15.
go back to reference Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12:71–79CrossRef Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R (1980) Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) 12:71–79CrossRef
16.
go back to reference Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B (1988) Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327–335CrossRefPubMed Bengtsson B, Eden S, Ernest I, Oden A, Sjogren B (1988) Epidemiology and long-term survival in acromegaly: a study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 223:327–335CrossRefPubMed
17.
go back to reference Ritchie CM, Atkinson AB, Kennedy AL, Lyons AR, Gordon DS, Fannin T, Hadden DR (1990) Acertainment and natural history of treated acromegaly in Northern Ireland. Ulster Med J 59:55–62PubMedPubMedCentral Ritchie CM, Atkinson AB, Kennedy AL, Lyons AR, Gordon DS, Fannin T, Hadden DR (1990) Acertainment and natural history of treated acromegaly in Northern Ireland. Ulster Med J 59:55–62PubMedPubMedCentral
18.
go back to reference Etxabe J, Gaztambide S, Latorre P, Vazquez JA (1993) Acromegaly: an epidemiological study. J Endocrinol Invest 16:181–187CrossRefPubMed Etxabe J, Gaztambide S, Latorre P, Vazquez JA (1993) Acromegaly: an epidemiological study. J Endocrinol Invest 16:181–187CrossRefPubMed
20.
go back to reference Rostomyan L, Daly AF, Beckers A (2015) Pituitary gigantism: causes and clinical characteristics. Ann Endocrinol (Paris) 76(6):643–649CrossRef Rostomyan L, Daly AF, Beckers A (2015) Pituitary gigantism: causes and clinical characteristics. Ann Endocrinol (Paris) 76(6):643–649CrossRef
Metadata
Title
Epidemiology of acromegaly: review of population studies
Authors
Aikaterini Lavrentaki
Alessandro Paluzzi
John A. H. Wass
Niki Karavitaki
Publication date
01-02-2017
Publisher
Springer US
Published in
Pituitary / Issue 1/2017
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-016-0754-x

Other articles of this Issue 1/2017

Pituitary 1/2017 Go to the issue